FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine, more specifically to absorbable polyether esters that have been found to reduce bacterial adhesion to materials such as medical devices and implants. Amorphous copolymers are used to produce a coating for medical devices and implants to reduce bacterial adhesion.
EFFECT: invention refers to new amorphous copolymers containing polyethylene diglycolate (PEDG) copolymerised with lactide-rich monomers.
15 cl, 4 dwg, 7 tbl, 13 ex
Authors
Dates
2015-02-10—Published
2010-10-26—Filed